We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+21.94%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$22.2B
AUM Growth
+$6.6B
Cap. Flow
+$3.75B
Cap. Flow %
16.89%
Top 10 Hldgs %
18.16%
Holding
1,735
New
565
Increased
342
Reduced
340
Closed
467

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$239M
2
AAPL icon
Apple
AAPL
+$213M
3
ELV icon
Elevance Health
ELV
+$188M
4
BMY icon
Bristol-Myers Squibb
BMY
+$184M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$166M

Top Sells

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$183M
2
ABBV icon
AbbVie
ABBV
+$149M
3
HUM icon
Humana
HUM
+$120M
4
FIS icon
Fidelity National Information Services
FIS
+$119M
5
MELI icon
Mercado Libre
MELI
+$103M

Sector Composition

Rank Sector Weight
1 Healthcare 27.33%
2 Technology 17.93%
3 Consumer Discretionary 11.98%
4 Financials 8.85%
5 Communication Services 8.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCYC
1051
Bicycle Therapeutics
BCYC
$288M
$585K ﹤0.01%
+32,567
New +$629K
PCRX icon
1052
Pacira BioSciences
PCRX
$974M
$582K ﹤0.01%
+9,703
New +$568K
ARQT icon
1053
Arcutis Biotherapeutics
ARQT
$3.26B
$581K ﹤0.01%
+20,661
New +$506K
VNOM icon
1054
Viper Energy
VNOM
$15.3B
$581K ﹤0.01%
50,052
-492,653
-91% -$4.79M
WGO icon
1055
Winnebago Industries
WGO
$906M
$580K ﹤0.01%
+9,685
New +$528K
TRIP icon
1056
TripAdvisor
TRIP
$1.26B
$579K ﹤0.01%
+20,124
New +$484K
CMTL icon
1057
Comtech Telecommunications
CMTL
$51.5M
$574K ﹤0.01%
+27,716
New +$485K
MMX
1058
DELISTED
Maverix Metals Inc. Common Shares
MMX
$574K ﹤0.01%
104,300
-33,600
-24% -$176K
MAX icon
1059
MediaAlpha
MAX
$830M
$573K ﹤0.01%
+14,683
New +$569K
AXNX
1060
DELISTED
Axonics, Inc. Common Stock
AXNX
$573K ﹤0.01%
+11,476
New +$539K
CRUS icon
1061
Cirrus Logic
CRUS
$6.11B
$570K ﹤0.01%
6,944
-6,429
-48% -$483K
OPRA
1062
Opera Ltd
OPRA
$1.79B
$568K ﹤0.01%
+62,180
New +$564K
FOLD
1063
DELISTED
Amicus Therapeutics
FOLD
$565K ﹤0.01%
+24,468
New +$500K
MSGS icon
1064
Madison Square Garden
MSGS
$9.43B
$564K ﹤0.01%
3,061
+363
+13% +$59.7K
NBHC icon
1065
National Bank Holdings
NBHC
$1.91B
$560K ﹤0.01%
17,115
+8,071
+89% +$256K
MRVL icon
1066
Marvell Technology
MRVL
$187B
$559K ﹤0.01%
+11,761
New +$509K
BPMC
1067
DELISTED
Blueprint Medicines
BPMC
$557K ﹤0.01%
+4,970
New +$524K
NGMS
1068
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
$557K ﹤0.01%
+14,652
New +$369K
MDXG icon
1069
MiMedx Group
MDXG
$622M
$556K ﹤0.01%
+61,211
New +$441K
NXRT
1070
NexPoint Residential Trust
NXRT
$641M
$555K ﹤0.01%
+13,114
New +$574K
IPOF
1071
DELISTED
Social Capital Hedosophia Holdings Corp. VI
IPOF
$553K ﹤0.01%
+44,970
New +$511K
CXW icon
1072
CoreCivic
CXW
$3.26B
$549K ﹤0.01%
+83,585
New +$601K
WABC icon
1073
Westamerica Bancorp
WABC
$1.35B
$539K ﹤0.01%
9,747
-11,026
-53% -$608K
HTHT icon
1074
Huazhu Hotels Group
HTHT
$13.2B
$531K ﹤0.01%
+11,779
New +$537K
MAN icon
1075
ManpowerGroup
MAN
$2.63B
$527K ﹤0.01%
5,833
-2,383
-29% -$196K
41 42
43
44 45

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q4 2020 Portfolio in Review

As of Q4 2020, Marshall Wace North America held 1,735 positions worth $22.2B, up 42% from $15.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace North America deployed $3.75B of net new capital in Q4 2020, opening 565 new positions and adding to 342 existing holdings. Its largest new stake was ExxonMobil: 2,686,885 shares worth $111M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Adobe, an estimated $183M trimmed.

  • Marshall Wace North America's largest Q4 2020 buy was ExxonMobil: 2,686,885 shares worth $111M.
  • Marshall Wace North America added most to Thermo Fisher Scientific in Q4 2020, an estimated $239M increase.
  • Marshall Wace North America's biggest Q4 2020 reduction was Adobe, cutting an estimated $183M.
  • Marshall Wace North America fully exited Baxter International in Q4 2020, selling an estimated $92.8M.
  • Marshall Wace North America's ten largest holdings make up 18% of its $22.2B portfolio in Q4 2020.
  • Marshall Wace North America opened 565 new positions and closed 467 in Q4 2020.
  • Marshall Wace North America's portfolio value rose 42% quarter-over-quarter to $22.2B.

Based on Marshall Wace North America's 13F filing for Q4 2020, filed 16 Feb 2021.